Senseonics Holdings, Inc. Common Stock Asset Resilience Ratio
Senseonics Holdings, Inc. Common Stock asset resilience ratio. Senseonics Holdings, Inc. Common Stock (SENS) has an Asset Resilience Ratio of 54.67% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Senseonics Holdings, Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Senseonics Holdings, Inc. Common Stock (2014–2024)
Asset resilience ratio of Senseonics Holdings, Inc. Common Stock from 2014 to 2024. This chart shows how Senseonics Holdings, Inc. Common Stock's Asset Resilience Ratio has changed over time. See financial agility of Senseonics Holdings, Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Senseonics Holdings, Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SENS asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $76.49 Million | 54.67% |
| Total Liquid Assets | $76.49 Million | 54.67% |
Asset Resilience Insights
- Very High Liquidity: Senseonics Holdings, Inc. Common Stock maintains exceptional liquid asset reserves at 54.67% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Senseonics Holdings, Inc. Common Stock Industry Peers by Asset Resilience Ratio
Compare Senseonics Holdings, Inc. Common Stock's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1 |
Medical Devices | 1.05% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Wellell Inc
TW:4106 |
Medical Devices | 2.43% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
Senseonics Holdings, Inc. Common Stock Asset Resilience Ratio by Year (2014–2024)
Senseonics Holdings, Inc. Common Stock asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Senseonics Holdings, Inc. Common Stock.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | $0.00 | $100.44 Million | -- |
| 2023-12-31 | 24.42% | $33.75 Million | $138.22 Million | -36.50pp |
| 2022-12-31 | 60.91% | $108.22 Million | $177.67 Million | +12.43pp |
| 2021-12-31 | 48.48% | $96.44 Million | $198.93 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $35.92 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $159.97 Million | -- |
| 2017-12-31 | 44.18% | $20.30 Million | $45.94 Million | +11.45pp |
| 2016-12-31 | 32.74% | $7.29 Million | $22.27 Million | -3.73pp |
| 2014-12-31 | 36.46% | $7.29 Million | $20.00 Million | -- |
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more